restenosis

restenosis

1. Surgical Treatment for Mitral Restenosis after Closed Mitral Commissurotomy: An Analysis of 108 Cases

108例二尖瓣闭式扩张术后再狭窄的外科治疗

2. In 1 patient,deformation of stent was not found by CT,but in stent restenosis was found by CAG and IVUS examination.

1例患者CT检查并未发现支架变形，但冠状动脉造影和IVUS检查发现支架内再狭窄；

3. The transcription factor,E2F,playing a critical role in cell cycle regulation,is involved in the pathophysiological process of restenosis.

2F是调控细胞周期进程一个关键的转录因子,而且在血管再狭窄的病理过程中也起着非常重要的作用。

4. Restenosis was demonstrated in 2 patients.

2例发生再狭窄；

5. To study the characteristics of VEGF and its geneexpression in CASS rabbit carotid arteries pre- and post-CEA, and toprovide scientific basis for experimental studying of VEGFpreventing restenosis after CEA.

2：研究CASS家兔CEA手术前后局部动脉壁VEGF及其基因表达的特点，为下一步VEGF防治CEA后再狭窄的实验研究提供科学依据。

6. After 6-12 months,the restenosis rate in the FBS group is less than that in the PES group(5.3% vs 21.9%,P<0.001).

6个月后随访结果国产西罗莫司洗脱支架组的支架再狭窄率明显低于紫杉醇洗脱支架组(5.3%比21.9%,P<0.001)。

7. At 6 months, the incidence of angiographic restenosis was 17% in the pioglitazone group and 35% in controls.

6个月时，吡格列酮组血管再狭窄的发生率为17%，而对照组为35%。

8. The sensitivity of DSE for the detection of restenosis in arteries with previous PTCA was 81.3%, the specificity 85.2%,and accuracy 84%.

DSE检测冠状动脉再狭窄的敏感性为 81.3% ,特异性为 85 .2% ,准确性为 84%。

9. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.

FLARE试验：氟伐他汀预防冠状动脉成形术成功后再狭窄的一项随机、安慰剂对照试验。氟伐他汀血管成形术再狭窄试验（FLARE）最终结果

10. MSCT shows 16 stents without in stent restenosis, 14 stents accord with conventional angiography.

MSCT显示16个支架通畅，与常规冠状动脉造影相符合的有14个；

11. The increases of MMP-2 after PCI are correlated to injury of myocardial cell. 3.The assay of MMP-2 before and after PCI may offer rationale for preventing in-stent restenosis.

PCI术前1天MMP-2在单支、双支、三支病变中的含量分别为8.56±3.49,10.39±6.58,21.36±8.52(ng/ml),两两比较差别有统计学意

12. Proliferation and migration of VSMC plays a key role in formation and progression of atherosclerosis，hypertension and in development of restenosis.

VSMC异常增殖、迁移和表型改变是动脉粥样硬化（atherosclerosis, As）、高血压和血管成形术后再狭窄等疾病中重要的病理改变。

13. Experimental Study on Vascular Restenosis after Ligatation of the Left Common Carotid Artery in Two Strains of Mouse

两种品系小鼠左颈总动脉结扎建立血管再狭窄模型实验研究

14. The recurrence of symptoms several years after an excellent clinical and hemodynamic result may be due to restenosis of the mitral value.

临床上和血液动力学上取得极好结果，如果过几年后症状复现，可能由二尖瓣重新狭窄所引起。

15. The primary outcome was the restenosis rate, based on quantitative coronary angiography (QCA) performed at study entry and again at six-month follow-up.

主要试验终点为再阻塞机率，根据定量式冠状动脉血管摄影（QCA），在试验前与试验开始后六个月各执行一次。

16. Prosthetic Valve Replacement for Patients with Mitral Restenosis

二尖瓣再狭窄人工瓣膜置换术

17. Keywords closed mitral commissurotomy;restenosis;reoperation;perioperative treatment;

二尖瓣闭式扩张术;再狭窄;再手术;围术期处理;

18. Statin Reduces In-stent Restenosis in Patients with Coronary Heart Disease; Influencing Factors and Implications

他汀类药物减少冠心病患者支架术后再狭窄的影响因素及意义

19. But stent installing in coronary can only reduce but cannot completely prevent restenosis.In-stent restenosis is still to remain the main factor to influence longterm result.

但冠脉内安装支架只能降低,并不能完全防止再狭窄的发生,支架内再狭窄仍是影响远期效果的主要因素。

20. However, this technique continues to be characterized by its propensity t o elicit passive results, such as restenosis, inflammation, thrombopoiesis, form ation of encrustation or stone.

但是,再狭窄、感染、凝血、硬壳或者结石的形成仍然是支架植入术后容易发生的问题。

21. However, this technique continues to be characterized by its propensity to elicit passive results, such as restenosis, inflammation, thrombopoiesis, formation of encrustation or stone.

但是,再狭窄、染、血、壳或者结石的形成仍然是支架植入术后容易发生的问题。

22. A striking exception is probucol, which retards atherosclerosis in carotid arteries and restenosis of coronary arteries after angioplasty.

但普罗布考是一个例外，它能够延缓冠状动脉血管成形术后再狭窄和颈动脉内粥样硬化的进展。

23. However, restenosis is the major limitation of the long-term success of this procedure.

但术后再狭窄率较高，成为限制其远期疗效的主要因素。

24. Irradiating Effect of Low Intensive Microwave on Restenosis of External Iliac Artery of Rabbit after Injury

低强度微波辐射对兔髂外动脉损伤后再狭窄的影响

25. Preventive role of introvascular low power red laser illumination on restenosis after balloon angioplasty in rabbits

低能量红激光局部照射预防血管成形术后再狭窄的实验研究

26. In vitro,argatroban could inhibit other roles of thrombin,such as tumor cell metastasis,inflammation and restenosis after angioplasty.

体内外研究表明,它还抑制凝血酶的其他作用,如可以抑制肿瘤转移、炎症过程及血管成形术后的再狭窄等。

27. Keywords Magnetotherapy;Cell division;Adjusting effect;Coronary restenosis;

关键词磁疗法;细胞分裂;调控作用;冠脉再狭窄;

28. Keywords Covered stent;Peripheral vessels;Restenosis;Endothelialization;

关键词覆膜支架;外周血管;再狭窄;内皮化;

29. Puzzle or Hope? Are Endothelial Progenitor Cell Capture Stents the Next Potential Treatment for Restenosis?

内皮祖细胞捕获支架的困惑与希望?

30. antip[ateleti percutaneous coronary interventionl restenosis

再狭窄

31. Keywords PCI;restenosis;endothelial cell;asiaticoside;endothelin;nitric oxide;

再狭窄;内皮细胞;积雪草甙;内皮素;一氧化氮;

32. Keywords restenosis;trapidil;vascular smooth muscle;

再狭窄;曲匹地尔;血管平滑肌;

33. Keywords Restenosis Drug-eluting stents Triptolide PCNA PDGF;

再狭窄;药物洗脱支架;雷公藤内酯醇;PCNA;PDGF;

34. In the coronary angiography follow-up cases, the frequency of KK genotype and E allele carriers in the patients with restenosis were 58.3%, 41.7% respectively.

再狭窄患者中KK纯合子和E等位基因携带基因型的频率分别为 5 8 3%、4 1 7% ;

35. Restenosis is a major problem in the field of percutaneous coronary intervention.

再狭窄是经皮冠状动脉介入治疗领域的难题。

36. The impaired fibrinolytic system after percutaneous coronary intervention (PCI) plays an important role in the development of restenosis.

冠心病介入治疗后纤溶系统功能受损在再狭窄的发生发展过程中起重要作用;

37. Analysis on the Risk Factors of Coronary Artery Restenosis in CAD Patients after PTCA

冠心病患者PTCA后无再流现象的危险因素分析

38. Keywords coronary bypass;restenosis;vascular smooth muscle cells;PDGF-B;peptide nucleic asid;

冠状动脉搭桥术;再狭窄;血管平滑肌细胞;血小板衍化生长因子;反义寡肽核酸;

39. Results Reprots mainly come from medical departments ,and the most adverse events on coronary stand are in-stent restenosis (ISR) and thrombosis.

冠状动脉支架不良事件主要表现为支架内再狭窄和血栓形成。结论冠状动脉支架的广泛应用使其安全性问题也日益得到关注。

40. Treatment of In-stent coronary restenosis with excimer laser angioplasty

准分子激光冠状动脉成形术治疗支架内再狭窄

41. Keywords Thrombin receptor;Antisense RNA;Restenosis;Smooth muscle cell proliferation;Polymerase chain reaction;

凝血酶受体;反义RNA;再狭窄;平滑肌细胞增生;聚合酶链反应;

42. The instant and late minimal lumen diameters(MLD),diameter stenoses(DS),and restenosis rates as well as acute lumen gain(ALG),acute recoil(AR) and acute recoil rate(ARR) after PTCA in two groups were compared.

分别比较术后即刻及远期定量冠状动脉造影最小血管径 (ML D)、狭窄度 (DS)、再狭窄率、即刻管腔获得 (AL G)、即刻血管弹性回缩 (AR)及弹性回缩率 (ARR)。

43. Keywords Cutting bolloon;In-stent restenosis;Coronary artery;

切割球囊;支架内再狭窄;冠状动脉;

44. Keywords cutting balloon;in-stent restenosis;Intravascular ultrasound;

切割球囊;支架内再狭窄;冠状动脉内超声;

45. Keywords arterial restenosis inflammation therapy;

动脉再狭窄;炎症;治疗;

46. Keywords Monocyte chemotactic protein 1;Antisense RNA;Restenosis;Nanoparticles;

单核细胞趋化蛋白-1;反义RNA;再狭窄;纳米粒子;

47. Experimental Study of Co-expression of Double Genes for Preventing Arterial Restenosis

双基因共表达预防血管再狭窄的实验研究

48. On the other hand, restenosis deeloped in 47% of patients, ersus reported rates of 28% for bare metal stents and 6% after drug-eluting stents.

另一方面，47%的患者出现了再狭窄，而应用裸支架的患者再狭窄发生率据报道是28%，而应用涂层支架的是6%。

49. Keywords bioabsorbable stent;polymers;restenosis;

可吸收支架;多聚物;再狭窄;

50. Pullback atherectomy for the treatment of in-stent restenosis: Clinical experience and follow-up angiography

后退式旋切导管对冠状动脉支架内再狭窄的治疗

51. The marked reduction in restenosis with drug-eluting stents compared with BMS may counterbalance the potential excess risk from late ST with drug-eluting stents.

和BMS相比，药物洗脱支架显著降低再狭窄率可能弥补/抵消潜在的因药物洗脱支架导致晚期血栓形成的危险。

52. To prevent restenosis following stenting, and design stent with better curative effect and less side effects are subjects in future studies.

因此，防止气道支架置入后再狭窄的发生及其处理，开发疗效更好、副作用更少的新支架是今后研究的热点方向。

53. At home and abroad to restenosis the prevention and treatment research is hot.

国内外对再狭窄的预防及治疗是研究热点。

54. Coronary restenosis continues to be a major limitation of percutaneous coronary intervention even in the era of intracoronary stenting.

在冠脉支架应用的时代,再狭窄仍然制约着经皮冠脉介入治疗。

55. Keywords tPA;gene;vascular injury;thrombus;endangium hyperplasia;vessel restenosis;

基因;血管损伤;血栓;内膜增生;血管再狭窄;

56. Matrix metalloproteinases participate in the development of Coronary Heart Disease (CHD),and play an important role in restenosis.

基质金属蛋白酶参与冠心病的发生发展过程,并在术后再狭窄中具有重要作用。

57. The Experiment Study on Composite Denshen Pilulae(CDP) in Prevention of Restenosis in Rabbits

复方丹参滴丸预防兔血管再狭窄的实验研究

58. Keywords PAPP-A;CD40L;Rat;Artery Injury;Restenosis;OX-LDL;Vascular smooth muscle cell（VSMC）;ACS;PCI;

大鼠;再狭窄;妊娠相关蛋白-A;OX-LDL;血管平滑肌细胞;妊娠相关蛋白A;血管成形术;

59. A New Modeling and Its Dynamic Pathologic Observation of Restenosis after Carotid Artery Balloon-injury in Rats

大鼠新型颈总动脉球囊损伤后狭窄模型的建立及其动态病理学观察

60. Model establishment and pathogenetic study of arterial restenosis in rats

大鼠颈动脉再狭窄模型的建立及其病理机制的初步研究

61. Inser JM,Kearney M,Bortman S,et al.Apoptosis in human atherosclerosis and restenosis[J].Circulation,1995 ;91 (11):2703-11.

孟振行,朱甫祥,韩彩丽,等.丹参对家兔实验性动脉粥样硬化预防作用的研究[J].心肺血管病杂志,1995;14(2):101-4.

62. Time course of early restenosis of rabbit carotid atherosclerosis model after carotid endarterectomy

家兔颈动脉粥样硬化模型颈动脉内膜剥脱术后的早期再狭窄过程

63. Evaluation of interventional treatment for diabetic foot should undertake not only the vascular stenosis and restenosis, but also the relief of clinical symptom and improvement of amputation level.

对糖尿病足疗效不只是评价血管狭窄与再狭窄，应该包括临床症状缓解情况，保肢和降低截肢平面等。

64. It's a new research of prevention and treatment restenosis with BPD-MA-PDT.

将BPD-MA-PDT应用到RS的防治是一个新的课题。

65. Developmental Study of Restenosis of Small-Caliber Prosthetic Vascular Grafts

小口径人工血管植入术后再狭窄的研究进展

66. Although CAS is a microinvasive technique, it has some potential complications, such as hemodynamic abnormalities, hyperperfusion syndrome, cerebral infarction, and restenosis.

尽管CAS是一种微创治疗方法,但仍然有许多潜在的并发症,如血流动力学异常、过度灌注综合征、脑梗死和再狭窄等。

67. Study on the Relation of Macrophages, T-lymphocytes and Mast Cells to Esophageal Restenosis after Stenting

巨噬细胞、T淋巴细胞和肥大细胞与食管支架术后再狭窄的相关研究

68. Smooth muscle cells migrate to injured site and proliferate, leading to intimal hyperplasia and vessel wall remodeling, which induces restenosis.

平滑肌细胞向损伤部位迁移发生增殖反应，新生内膜大量增生，血管壁重构引起支架内再狭窄。

69. Inhibitory Effect of Photodynamic Therapy on Vein Graft Restenosis in Rabbits[J].

引用该论文 程智广,余翼飞,顾瑛,刘凡光.

70. Inhibition of intimal hyperplasia or improvement of intima formation and vessel wall remodeling can effectively prevent restenosis.

抑制血管内膜过度增生或改善新生内膜形成以及血管重塑过程均可有效防止再狭窄。

71. antiplateleti percutaneous coronary interventionl restenosis

抗血小板

72. Both found that some patients with more serious conditions were more likely to suffer a renarrowing of the artery.This is called restenosis.

据项研究发现，病情严重的患者发生动脉再次变窄的可能性会更高些，这种现象被称之为“再狭窄”。

73. Abstract： Objective:To investigate the inhibit effect of hyperplasia of the endovascular brachytherapy for the restenosis after percutaneous transluminal coronary angioplasty(PTCA).

摘 要： 目的：观察血管腔内放疗对经皮腔内冠状动脉成形术(PTCA)后再狭窄的防治作用。

74. Restenosis is a major complication after percutaneous transluminal coronary intervention.

摘要冠脉再狭窄是冠状动脉介入术后最主要的并发症之一。

75. Restoration of endothelial integrity and improvement of endothelial function is the most important therapeutic methods to prevent restenosis after percutaneous coronary intervention.

摘要在冠状动脉内介入治疗后尽快恢复血管内皮的完整性，尽早恢复正常的血管内皮功能是预防冠状动脉内介入治疗后再狭窄的最重要的治疗手段。

76. We report an unusual complication of cutting balloon (CB) angioplasty during treatment of aorto-ostial in-stent restenosis.

摘要我们报告使用刀片气球治疗主动脉侧支开口支架内狭窄的一个罕见并发症。

77. In-stent restenosis represents an excessive form of healing of localized injury.The major mechanism of restenosis is neointimal hyperplasia.

摘要支架术后再狭窄是机体对损伤的一种过度愈合反应，新生内膜增殖是其主要发生机制。

78. The problem of subacute thrombosis and restenosis is still not being resolved with stainless steel and cobalt-chromium alloy-based drug-eluting stern fundamentally.

摘要目前以不锈钢和钴铬合金为基础的药物洗脱支架不能从根本上解决亚急性血栓形成和再狭窄的问题。

79. Objective To investigate the feasibility of asiaticoside in preventing restenosis after percutaneous coronary intervention (PCI).

摘要目的探讨积雪草甙防治经皮冠状动脉介入治疗(PCI)术后再狭窄的可行性。

80. Objective To investigate the effect of Sini decoction (SND) in preventing vascular restenosis and protecting against oxidative stress after rabbit iliac artery balloon injury.

摘要目的通过球囊损伤兔髂动脉造成动脉损伤的动物模型，观察四逆汤对损伤后动脉内膜的保护和修复作用，以及对氧化应激的影响。